Safety of percutaneous liver biopsy in infants less than three months old

R K Azzam1, E M Alonso, K M Emerick

  • 1Department of Pediatrics, Children's Memorial Hospital, Northwestern University Feinberg Medical School, Chicago, Illinois 60614, USA.

Insights

Percutaneous liver biopsy (PLB) in infants under 3 months showed an 18% complication rate, with sedation-related issues being most common. Careful monitoring is crucial for this pediatric procedure.

Area of Science:

  • Pediatric Gastroenterology
  • Interventional Radiology
  • Neonatal Medicine

Background:

  • Percutaneous liver biopsy (PLB) is a common diagnostic procedure.
  • Data on PLB safety and outcomes in young infants is limited.

Purpose of the Study:

  • To evaluate the safety, outcomes, and complications of PLB in infants aged 0 to 3 months.
  • To identify risk factors associated with PLB complications in this age group.

Main Methods:

  • Retrospective review of hospital records for infants under 3 months who underwent PLB.
  • Analysis of complications and potential risk factors.

Main Results:

  • Sixty-six PLBs were performed in 63 infants.
  • An overall complication rate of 18% was observed.
  • Sedation-related respiratory issues were the most frequent complications (7/12).

Conclusions:

  • PLB in young infants carries a higher risk of complications compared to older children.
  • Complications are particularly related to sedation management in this population.
Abstract

Related Concept Videos